Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Electrical Stimulation Patch Could Alleviate Migraine

By HospiMedica International staff writers
Posted on 17 Mar 2017
A wireless neurostimulation patch that blocks pain signals to the brain may one day replace drugs for the treatment of migraine, according to a new study.

The Nerivio patch, a product of Theranica, consists of smart chip that is responsible not only for the creation of electrical nerve stimulation (ENS) and neuromuscular electrical stimulation (NMES) pulses as per the user’s definitions, but also incorporates features such as therapy efficiency control and safety mechanisms. More...
To begin therapy, the device is first connected to a smartphone app; when instructed, it generates electrical pulses, which stimulate sensory nerves under the skin via rubber electrode patches.

In a study conducted by researchers at the Israel Institute of Technology, 71 adults with episodic migraine averaging two to eight migraine attacks every month were instructed to apply the Nerivio device to their upper arm, using an armband. The devices were then programmed to randomly give either placebo (sham) stimulation at a very low frequency, or one of four levels of active stimulation; the stimulation was designed to not be painful. A total of 299 migraine episodes were treated with the device during the study.

The results showed that during active stimulation at the three highest levels, 64% had a reduction in their pain by at least 50% two hours after the treatment, compared to 26% of people during the sham stimulation. For those who started with moderate to severe pain, it was reduced to mild or no pain in 58% of people at the highest level of stimulation. In addition, 30% said they had no pain after receiving the highest level of stimulation, compared to 6% of those receiving the sham stimulation. The study was published in the March 1, 2017, issue of Neurology.

"These results are similar to those seen for the triptan medications for migraine; people with migraine are looking for non-drug treatments, and this new device is easy to use, has no side effects, and can be conveniently used in work or social settings,” said lead author David Yarnitsky, MD, of the Technion Faculty of Medicine. “Starting the stimulation within 20 minutes of the start of a migraine was more effective, with 47% reducing pain when starting early, compared to 25% who started after 20 minutes.”

Migraine is a debilitating condition characterized by moderate to severe headaches, and is about three times more common in women. The typical migraine headache is unilateral and pulsating in nature, and lasts from four to 72 hours; symptoms include nausea, vomiting, photophobia (increased sensitivity to light), phonophobia (increased sensitivity to sound), and is aggravated by routine activity. Approximately one-third of people who suffer from migraine headaches perceive auras – unusual visual, olfactory, or other sensory experiences that are a sign that the migraine will soon occur.


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Gold Member
Electrode Solution and Skin Prep
Signaspray
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.